Riskpilot← Back to searchSign inGet full accessSWPS Pharma AB
ABBankruptOrg 5590003025Retail sale of pharmaceutical products · NACE 4773Est. 20150 employees
Revenue 2022
SEK 0
EBITDA margin
—
Equity ratio
-98.0%
Financial strength
Net profit 2022
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | — |
| Total assets | SEK 350K | +0% |
| Equity | SEK -343K | +0% |
| Employees | 0 | — |
Legal name
SWPS Pharma AB
Org number
5590003025
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
14 januari 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva partihandel med läkemedel, samt därmed förenlig verksamhet.
Address
Email
thobias.almen@swps.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 373 | 1 191 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | 33 | 27 | — | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 33 | 27 | 0 | 0 |
| Net financials | — | — | −9 | — | — |
| Profit before tax | 0 | 34 | 18 | 0 | 0 |
| Tax | −0 | −8 | −8 | −0 | −0 |
| Net profit | 0 | 26 | 10 | 0 | 0 |
| Item | 2019 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 43 | 137 | 803 | 350 | 350 |
| Equity | 43 | 69 | 79 | −343 | −343 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 68 | 724 | 693 | 693 |
| Total debt | — | 68 | 724 | 693 | 693 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192022
Equity ratio
-98.0%
This company
38.2%
Market median
-357% vs market
20192022
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192022
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192022
Debt / equity
2.02×
This company
0.62×
Market median
-226% vs market
20192022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-05-01 – 2019-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SWPS Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Hilding Almén | Board of Directors | 0 companies |
| Karl Hilding Andreas Almén | Board of Directors | 0 companies |
| Karl Hilding Thobias Almén | Chairman | 0 companies |